Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID

NCT06597396 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Post-COVID Condition
Fatigue Symptom

Interventions

DRUG: Abrocitinib
DRUG: Placebo

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]